Last reviewed · How we verify
NCT07247331: AOT-CP
The Effect of Action Observation Therapy on Spasticity, Motor Function, and Balance in Children With Cerebral Palsy
trial testing action observation therapy in Cerebral Palsy in 36 participants. Completed in 7 July 2024.
15 March 2024
Quick facts
| Lead sponsor | Suleyman Demirel University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 36 |
| Start date | 2 December 2022 |
| Primary completion | 15 March 2024 |
| Estimated completion | 7 July 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- action observation therapy
Conditions studied
- Cerebral Palsy — all drugs for Cerebral Palsy →
- Spastic Diplegia Cerebral Palsy — all drugs for Spastic Diplegia Cerebral Palsy →
- Hemiplegic Cerebral Palsy — all drugs for Hemiplegic Cerebral Palsy →
Sponsor
Suleyman Demirel University
Who can join
Adults 5 to 13, any sex, with Cerebral Palsy or Spastic Diplegia Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In our randomized controlled study, which aims to investigate the contribution of Action Observation Therapy to rehabilitation by examining the effect of Action Observation Therapy on spasticity, gross motor function, balance and participation in children with spastic diplegic and hemiplegic cerebral palsy, the effectiveness of Action Observation Therapy to be applied in the home environment and accompanied by a physiotherapist will be investigated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07247331
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of action observation therapy
Trials testing the same drug.
- NCT04943601 — Action Observation Therapy for Stroke · NA · completed
Other recruiting trials for Cerebral Palsy
Currently open trials in the same condition.
- NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
- NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
- NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
- NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
- NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting
Other Suleyman Demirel University trials
Trials by the same sponsor.
- NCT07429513 — Promoting Environmental Responsibility Toward Climate Change · NA · not yet recruiting
- NCT07523087 — Effect of a Brief Mindfulness-Based Training on First Clinical Day Stress in First-Year Nursing Students · NA · completed
- NCT07245355 — Contribution of Recreational Exercises to Balance and Muscle Strength in Osteoporosis Risk · NA · not yet recruiting
- NCT07333391 — Individualized Grief Support With Swanson Model · NA · not yet recruiting
- NCT07382830 — Effectiveness of a Visual Feedback Exercise Program Following Lumbar Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07247331 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Suleyman Demirel University
- Last refreshed: 25 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07247331.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing